Metraipolis › archive › dc_3a1f4ccff88e
Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo — Europe PMC PMID:38722955
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/38722955
- DOI
- 10.1371/journal.pone.0302856
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T18:46:11.922Z
- SHA-256 of the archived text
d5e2f74f0aeb2a62071c64741f444756d03b44cae9564420bc5f06483932558d- Stable URL of this page
https://metraipolis.com/documento/dc_3a1f4ccff88e
How to cite
Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo — Europe PMC PMID:38722955 — Europe PMC (en), https://europepmc.org/article/MED/38722955 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_3a1f4ccff88e (Metraipolis archive dc_3a1f4ccff88e, sha256 d5e2f74f0aeb2a62071c64741f444756d03b44cae9564420bc5f06483932558d)
BibTeX
@misc{dc3a1f4ccff88e,
title = {Mutation of SIVA, a candidate metastasis gene identified from clonally related bilateral breast cancers, promotes breast cancer cell spread in vitro and in vivo — Europe PMC PMID:38722955},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/38722955},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_3a1f4ccff88e; sha256 d5e2f74f0aeb2a62071c64741f444756d03b44cae9564420bc5f06483932558d},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/38722955. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Metastasis is the most dreaded outcome after a breast cancer diagnosis, and little is known regarding what triggers or promotes breast cancer to spread distally, or how to prevent or eradicate metastasis effectively. Bilateral breast cancers are an uncommon form of breast cancers. In our study, a percentage of bilateral breast cancers were clonally related based on copy number variation profiling. Whole exome sequencing and comparative sequence analysis revealed that a limited number of somatic mutations were acquired in this "breast-to-breast" metastasis that might promote breast cancer distant spread. One somatic mutation acquired was SIVA-D160N that displayed pro-metastatic phenotypes in vivo and in vitro. Over-expression of SIVA-D160N promoted migration and invasion of human MB-MDA-231 breast cancer cells in vitro, consistent with a dominant negative interfering function. When introduced via tail vein injection, 231 cells over-expressing SIVA-D160N displayed enhanced distant spread on IVIS imaging. Over-expression of SIVA-D160N promoted invasion and anchorage independent growth of mouse 4T1 breast cancer cells in vitro. When introduced orthotopically via mammary fat pad injection in syngeneic Balb/c mice, over-expression of SIVA-D160N in 4T1 cells increased orthotopically implanted mammary gland tumor growth as well as liver metastasis. Clonally related bilateral breast cancers represented a novel system to investigate metastasis and revealed a role of SIVA-D160N in breast cancer metastasis. Further characterization and understanding of SIVA function, and that of its interacting proteins, may elucidate mechanisms of breast cancer metastasis, providing clinically useful biomarkers and therapeutic targets. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2024 (prima pubblicazione 2024-05-09). Identificativi: PMID 38722955 · PMCID PMC11081324 · DOI 10.1371/journal.pone.0302856. Descrittori MeSH principali: Breast Neoplasms; Neoplasm Metastasis; Apoptosis Regulatory Proteins. Pagina: https://europepmc.org/article/MED/38722955 — https://doi.org/10.1371/journal.pone.0302856. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T17:12:53.136Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.